Genedrive (GDR) RNS Announcements

Add to Alert list
Date Time Source Announcement
25 Nov 2011 12:00 PM
RNS
Cash Placing
09 Nov 2011 07:00 AM
RNS
2011 Annual Report and Accounts & Notice of AGM
11 Oct 2011 07:00 AM
RNS
Final Results
07 Oct 2011 12:43 PM
RNS
Director/PDMR Shareholding
05 Oct 2011 07:00 AM
RNS
Human DNA Identification Collaboration
27 Sep 2011 07:00 AM
RNS
GenedriveT passes first in-field Tuberculosis test
04 Aug 2011 07:00 AM
RNS
Pre Close Trading Update
30 Jun 2011 12:00 PM
RNS
Director/PDMR Shareholding
28 Jun 2011 07:00 AM
RNS
Tuberculosis Diagnostic Collaboration
23 Jun 2011 04:38 PM
RNS
Holding(s) in Company
19 May 2011 05:20 PM
RNS
Holding(s) in Company
19 Apr 2011 12:32 PM
RNS
Holding(s) in Company
19 Apr 2011 12:28 PM
RNS
Holding(s) in Company
08 Apr 2011 09:20 AM
RNS
Holding(s) in Company
05 Apr 2011 02:34 PM
RNS
Director/PDMR Shareholding
04 Apr 2011 12:41 PM
RNS
Holding(s) in Company
04 Apr 2011 09:35 AM
RNS
Holding(s) in Company
29 Mar 2011 07:00 AM
RNS
Director/PDMR Shareholding
29 Mar 2011 07:00 AM
RNS
Interim Results
28 Mar 2011 09:47 AM
RNS
Holding(s) in Company
17 Mar 2011 09:23 AM
RNS
Re Agreement - Replacement
17 Mar 2011 07:20 AM
RNS
Re Agreement
28 Feb 2011 01:22 PM
RNS
Interim Results Announcement
18 Feb 2011 04:26 PM
RNS
Holding(s) in Company
05 Jan 2011 11:41 AM
RNS
Directors' Shareholdings and
20 Dec 2010 11:36 AM
RNS
Adviser - Change of Name
26 Nov 2010 03:48 PM
RNS
AGM results
03 Nov 2010 07:00 AM
RNS
Commercial Update
05 Oct 2010 07:00 AM
RNS
Final Results
04 Oct 2010 12:07 PM
RNS
Director/PDMR Shareholding
10 Aug 2010 11:12 AM
RNS
Holding(s) in Company
29 Jul 2010 07:00 AM
RNS
Pre close statement
23 Jul 2010 01:50 PM
RNS
Holding(s) in Company
02 Jul 2010 10:53 AM
RNS
Director/PDMR Shareholding
30 Apr 2010 09:42 AM
RNS
Holding(s) in Company
01 Apr 2010 07:00 AM
RNS
Director's Shareholding Updat
09 Mar 2010 07:00 AM
RNS
Change of Adviser
09 Mar 2010 07:00 AM
RNS
Half Yearly Report
24 Feb 2010 09:55 AM
RNS
Half Yearly Report
04 Jan 2010 01:43 PM
RNS
Director/PDMR Shareholding
09 Dec 2009 05:09 PM
RNS
Holding(s) in Company
02 Dec 2009 07:00 AM
RNS
Result of AGM
01 Dec 2009 05:34 PM
RNS
Holding(s) in Company
01 Dec 2009 05:33 PM
RNS
Holding(s) in Company
01 Dec 2009 11:11 AM
RNS
Holding(s) in Company
30 Nov 2009 02:50 PM
RNS
Holding(s) in Company
20 Nov 2009 08:31 AM
RNS
Cash Placing
04 Nov 2009 02:38 PM
RNS
Posting of Annual Report and
23 Oct 2009 09:57 AM
RNS
Holding(s) in Company
21 Oct 2009 04:58 PM
RNS
Holding(s) in Company

Genedrive plc is a medical equipment company based in Manchester, UK that develops and sells point-of-care molecular diagnostic platforms. Their products are used in healthcare settings, particularly in emergency medicine, for patient stratification and disease detection. Genedrive's goal is to improve clinical outcomes with easy-to-use tests. 

 Genedrive's major products include:
Genedrive CYP2C19 ID Kit: A rapid test that establishes metaboliser status in time-critical settings
Genedrive MT-RNR1 ID Kit: The world's first point-of-care genetic test to reduce the risk of aminoglycoside induced hearing loss

Genedrive was founded on contract research services for pharmaceutical and biotech companies, and was originally named Epistem Holdings Inc. when it was floated on the London AIM market in 2007. The company was renamed genedrive plc in 2016 to reflect its new focus on molecular diagnostics, and divested its contract research services divisions in 2018.

GDR share price launched at 129p in 2007. 

UK 100

Latest directors dealings